What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many shareholders. This was partly due to its softer quarterly results and might have investors contemplating their next move.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with Myriad Genetics (NASDAQ:MYGN).
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Flowserve (NYSE:FLS) and the rest of the gas and liquid handling stocks fared in Q4.
(Bloomberg) -- Thailand will provide tax incentives for investments in the nation’s equity market that has underperformed peers this year amid foreign outflows. Most Read from BloombergNJ College to Merge With State School After Financial StressNYC Congestion Pricing Toll Gains Support Among City ResidentsBuffalo’s Billion-Dollar Freeway Fix Is on Ice, But Not Because of TrumpWhere New York City's Zoning Reform Will Add HousingInside the ‘Not Architecture’ of High Line Designers Diller Scofidio
Target is facing tough times as consumers cut back on spending. It's also at the center of culture war controversies over DEI and Pride.
Wall Street tumbled amid tariff-driven recession fears in the US economy, triggering sharp selloffs in the big tech stocks, wiping out billions of euros in market valuation.View on euronews
US stock futures held steady after another brutal sell-off rocked Wall Street and deepened fears about the economy's trajectory.
The 4% drop in the Nasdaq on Monday marked its worst day in years as Trump refused to rule out recession.
U.S. stocks finally caught up overnight with what currency and bond markets have been saying for several weeks: A slowdown is coming. Tesla shares have halved since their post-election peaks and the dollar, which had been rising in anticipation of Donald Trump's policies, has now begun sliding as he slaps tariffs on his neighbours. Citi downgraded its U.S. asset allocation recommendation, cutting stocks to "neutral" from "overweight" after the market closed, saying that for the next few months at least it's not clear that the U.S. economy's outperformance can continue.
All seven tech darlings tanked on Monday, pushing the Nasdaq down 3%.